Asymptotic bubble evolutions of the Rayleigh–Taylor instability

We examine the multiple harmonic model for the single-mode Rayleigh–Taylor instability, and present a new class of the asymptotic solution for the bubble evolution. Previously reported solutions for the bubble curvature and velocity from the model were quantitatively different from other theoretical models and numerical results, for small density jumps. The discrepancy between the theoretical models is resolved by our new approach to the model. Our solution agrees with the Layzer–Goncharov model, and gives the independence of the bubble curvature on the density ratio.     

Time of acquisition and high spatial resolution mass spectrometry imaging

The field of mass spectrometry imaging (MSI) is constantly evolving to analyze a diverse array of biological systems. A common goal is the need to resolve cellular and subcellular heterogeneity with high spatial resolution. As the field continues to progress towards high spatial resolution, other parameters must be considered when developing a practical method. Here, we discuss the impacts of high spatial resolution on the time of acquisition and the associated implications they have on an MSI analysis (e.g., area of the region of interest). This work presents a brief tutorial serving to evaluate high spatial resolution MSI relative to time of acquisition and data file size.     

Polymer-modification of an anti-cancer drug: effects on hydrodynamic properties

Coupling of a hydrophobic pharmaceutical agents with the hydrophilic poly(ethylene oxide) chain can make the drug water soluble which is necessary for some applications. The modification of the polymer chain results in a different solution behaviour of the macromolecules compared with the unmodified polymer. There are strong indications that shape and rigidity of the modified molecule differ significantly from the simple chain. Some results from measurements of the self-diffusion coefficient and solution viscosity are discussed. The results are important for further engineering on active drug systems.